Niraparib
-
Post Date:
Dec 21,2024
-
Expiry Date:
Jun 19,2025
-
Detailed Description:
Cas No. :1038915-60-4
Niraparib (trade name Zejula) is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer. Niraparib was granted fast track designation by the US Food and Drug Administration (FDA), and Tesaro submitted a new drug application in 2016.
-
CAS Registry Number:
1038915-60-4
-
Synonyms:
;(S)-2-(4-(Piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide;
Inquiry